[go: up one dir, main page]

SE8104625L - Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi - Google Patents

Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi

Info

Publication number
SE8104625L
SE8104625L SE8104625A SE8104625A SE8104625L SE 8104625 L SE8104625 L SE 8104625L SE 8104625 A SE8104625 A SE 8104625A SE 8104625 A SE8104625 A SE 8104625A SE 8104625 L SE8104625 L SE 8104625L
Authority
SE
Sweden
Prior art keywords
inhibitors
therapy
aromatas
prophylax
application
Prior art date
Application number
SE8104625A
Other languages
Unknown language ( )
English (en)
Other versions
SE462639B (sv
Inventor
H-U Schweikert
U Tunn
T Senge
F Neumann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE8104625L publication Critical patent/SE8104625L/sv
Publication of SE462639B publication Critical patent/SE462639B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE8104625A 1981-05-22 1981-07-31 Anvaending av aromatashaemmare foer framstaellning av laekemedel foer profylax och behandling av benign prostatahyperplasi SE462639B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813121153 DE3121153A1 (de) 1981-05-22 1981-05-22 "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"

Publications (2)

Publication Number Publication Date
SE8104625L true SE8104625L (sv) 1982-11-23
SE462639B SE462639B (sv) 1990-08-06

Family

ID=6133383

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8104625A SE462639B (sv) 1981-05-22 1981-07-31 Anvaending av aromatashaemmare foer framstaellning av laekemedel foer profylax och behandling av benign prostatahyperplasi

Country Status (13)

Country Link
US (1) US4596797A (sv)
JP (1) JPS57193411A (sv)
AU (1) AU563524B2 (sv)
BE (1) BE890521A (sv)
CH (1) CH648485A5 (sv)
DE (1) DE3121153A1 (sv)
DK (1) DK354781A (sv)
GB (1) GB2100601B (sv)
IT (1) IT1168028B (sv)
LU (1) LU83544A1 (sv)
NL (1) NL8103874A (sv)
SE (1) SE462639B (sv)
ZA (1) ZA823500B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
ES2222633T3 (es) * 1989-07-07 2005-02-01 Endorecherche Inc. Terapia combinada para la profilaxis y/o el tratamiento de la hiperplasia prostatica benigna.
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
WO1992017489A1 (fr) * 1991-03-28 1992-10-15 Teikoku Hormone Mfg. Co., Ltd. Nouveau derive oxa- ou azasteroide
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
PL350291A1 (en) 1998-12-23 2002-12-02 Searle & Co Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6649645B1 (en) 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
US7939517B2 (en) * 2004-07-21 2011-05-10 Kneller Bruce W 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses
EP1854465A1 (en) 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
US20080245375A1 (en) * 2007-04-05 2008-10-09 Medtronic Vascular, Inc. Benign Prostatic Hyperplasia Treatments
PL2949361T3 (pl) * 2007-11-13 2017-09-29 Athenion Ag Steroidy C-19 do leczenia celulitu
WO2011127232A2 (en) 2010-04-08 2011-10-13 Emory University Substituted androst-4-ene diones
US20160361380A1 (en) 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function
EP3666276A1 (en) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US4055641A (en) * 1976-05-10 1977-10-25 Richardson-Merrell Inc. Method of treating benign prostatic hypertrophy
DE2817157A1 (de) * 1978-04-17 1979-10-25 Schering Ag Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3362176D1 (en) * 1982-07-14 1986-03-27 Akzo Nv Novel 19-thio-androstane derivatives

Also Published As

Publication number Publication date
IT8124117A0 (it) 1981-09-24
DE3121153C2 (sv) 1991-06-20
LU83544A1 (de) 1981-12-01
GB2100601B (en) 1986-02-05
NL8103874A (nl) 1982-12-16
AU563524B2 (en) 1987-07-16
DK354781A (da) 1982-11-23
GB2100601A (en) 1983-01-06
IT1168028B (it) 1987-05-20
US4596797A (en) 1986-06-24
JPS57193411A (en) 1982-11-27
SE462639B (sv) 1990-08-06
CH648485A5 (de) 1985-03-29
AU8407482A (en) 1982-11-25
BE890521A (fr) 1982-03-29
DE3121153A1 (de) 1982-12-09
JPH0150206B2 (sv) 1989-10-27
ZA823500B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
SE8104625L (sv) Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi
SE8104624L (sv) Anvendning av kombinationen av en aromatashemmare med ett antindrogent medel for profylax och terapi av prostatahyperaplasi
NO981392L (no) Substituerte pyrazolylbenzensulfonamider for anvendelse i veterinµrterapi som antiinflammatorisk middel
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
NO893240D0 (no) Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer.
LV11894A (lv) Jauni hromana un tiohromana atvasinajumi
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
NO164219C (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
GR3029490T3 (en) Use of leflunomid for the inhibition of tumor necrosis factor alpha.
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
NO890046D0 (no) Disubstituerte pyridiner.
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
NO922136L (no) Anvendelse av gibberelliner for behandling av prostatitisog psoriasis
DE69305348D1 (de) Proteintyrosinphosphatase alpha - Inhibitoren zur Tumorbehandlung
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
SE7905810L (sv) Spiroketaliner och deras anvendningar
DK225689A (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
SE7809880L (sv) Vaccin for profylax och behandling av clostridiosis hos djur och fjederfe
NO864272L (no) Fremgangsmaate og anordning for haandtering av boreroer.
SE8202962L (sv) 2-metoxifenylestrar av n-substiterade aminosyror, forfarande for deras framstellning och farmaceutiska beredningar innehallande desamma

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8104625-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8104625-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8104625-2

Format of ref document f/p: F